000 | 01978 a2200493 4500 | ||
---|---|---|---|
005 | 20250517022030.0 | ||
264 | 0 | _c20151221 | |
008 | 201512s 0 0 eng d | ||
022 | _a1873-3913 | ||
024 | 7 |
_a10.1016/j.cellsig.2015.03.002 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aVlahava, Virginia-Maria | |
245 | 0 | 0 |
_aCD40 ligand exhibits a direct antiviral effect on Herpes Simplex Virus type-1 infection via a PI3K-dependent, autophagy-independent mechanism. _h[electronic resource] |
260 |
_bCellular signalling _cJun 2015 |
||
300 |
_a1253-63 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAnthracenes _xpharmacology |
650 | 0 | 4 |
_aAntiviral Agents _xpharmacology |
650 | 0 | 4 |
_aAutophagy _xdrug effects |
650 | 0 | 4 | _aAutophagy-Related Protein 5 |
650 | 0 | 4 |
_aBenzylamines _xpharmacology |
650 | 0 | 4 |
_aCD40 Ligand _xgenetics |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCell Nucleus _xmetabolism |
650 | 0 | 4 |
_aChromones _xpharmacology |
650 | 0 | 4 |
_aHerpes Simplex Virus Protein Vmw65 _xmetabolism |
650 | 0 | 4 |
_aHerpesvirus 1, Human _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aJNK Mitogen-Activated Protein Kinases _xantagonists & inhibitors |
650 | 0 | 4 |
_aMacrolides _xpharmacology |
650 | 0 | 4 |
_aMicrotubule-Associated Proteins _xantagonists & inhibitors |
650 | 0 | 4 |
_aMorpholines _xpharmacology |
650 | 0 | 4 |
_aPhosphatidylinositol 3-Kinases _xmetabolism |
650 | 0 | 4 | _aPhosphoinositide-3 Kinase Inhibitors |
650 | 0 | 4 |
_aQuinazolines _xpharmacology |
650 | 0 | 4 | _aRNA Interference |
650 | 0 | 4 |
_aRNA, Small Interfering _xmetabolism |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 |
_aVirus Replication _xdrug effects |
700 | 1 | _aEliopoulos, Aristides G | |
700 | 1 | _aSourvinos, George | |
773 | 0 |
_tCellular signalling _gvol. 27 _gno. 6 _gp. 1253-63 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.cellsig.2015.03.002 _zAvailable from publisher's website |
999 |
_c24702942 _d24702942 |